Synonyms: TNP-2198
Compound class:
Synthetic organic
Comment: Rifasutenizol (formerly TNP-2198) is a rifamycin-nitroimidazole conjugate antibacterial compound [1]. Note that there is some ambiguity in the literature and online chemistry resources as to the precise stereochemistry of this ligand. We have drawn the structure as depicted in its INN record.
|
|
No information available. |
Summary of Clinical Use |
Rifasutenizol is being evaluated as a treatment for Helicobacter Pylori infections. |
Clinical Trials | |||||
Clinical Trial ID | Title | Type | Source | Comment | References |
NCT05857163 | Efficacy and Safety of Rifasutenizol (TNP 2198) in Participants With H. Pylori Infection | Phase 3 Interventional | TenNor Therapeutics Inc. | ||
NCT06076681 | A Study to Evaluate Preliminary Helicobacter Pylori Eradication After Multiple Doses of TNP-2198 Capsules Combined With Rabeprazole Sodium Enteric-coated Tablets, or Rabeprazole Sodium Enteric-coated Tablets and Amoxicillin Capsules | Phase 1/Phase 2 Interventional | TenNor Therapeutics Inc. | ||
NCT06076694 | Efficacy and Safety After Multiple Doses of TNP-2198 Capsules, Rabeprazole Sodium Enteric-coated Tablets and Amoxicillin Capsules in Helicobacter Pylori Infected-positive Participants | Phase 2 Interventional | TenNor Therapeutics Inc. |